The National Immunization Technical Advisory Group (NTAGI) has approved Serum Institute’s Kovovax for use on children aged 12-17 years. News agency ANI has given this information quoting sources. No information has been revealed about when the vaccination will start. Earlier, the DGCI had approved the vaccine for children in the age group of 6-12 years. Bharat Biotech’s Covaccine has been approved for children in this age group. This decision was taken after the results of the trial.
In view of the increasing cases of Corona, on Wednesday, PM Narendra Modi had a review meeting with the Chief Ministers of all the states. During this, he had talked about emphasizing on the vaccination campaign. In such a situation, after getting the approval of Kovovax, this campaign can be expected to accelerate even more.
After the schools were fully opened, the parents of the children were very worried about Corona. However, parents can breathe a sigh of relief once the vaccine is approved for children. The use of Covaxin for children 6 to 12 years of age, Corvax for children aged 5 to 12 years and ZyCoV-D for children above 12 years of age is approved.
Let us tell you that while taking strong steps in the ongoing war against Corona, the central government had made a big announcement regarding the booster dose. All adults over the age of 18 years can get precaution doses at private vaccination centers. This campaign has started from 10th April. People who are above 18 years of age and 9 months have passed since the second dose of corona vaccine can take the precaution dose.
About 96 percent of the country’s population has been given the first dose of the anti-Covid-19 vaccine. However, according to the vaccine tracker of the American newspaper New York Times, this figure in India is 73 percent.